Genomic Instability and Gene Therapeutics in Neurological Diseases Conference - Neurodegeneration: From Causes to Therapy

5–8 March 2018
Cancun, Mexico
 

With the rapidly emerging new tools including genomics, bioinformatics, metabolomics and proteomic analysis and new powerful editing tools such as CRISPR/CAS9 we are getting closer to more defined understanding of the complex cellular pathways underpinning neurodegeneration, which underlie many debilitating pathological and age-associated neurological demise. This is a great opportunity to assemble a rich programme of international speakers to address the latest advances from basic research to clinical applications in disorders of the central nervous system.

The conference will primarily focus on amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD), spinal muscular atrophy (SMA), Alzheimer’s disease/dementia, and repeat expansion disorders with translational spin focussing on recent advances in gene based-therapeutics.

Our aim is to share ideas, exchange knowledge and inspire young and established investigators to embrace new research directions. The conference will be chaired by Sherif El-Khamisy and Mimoun Azzouz together with leaders in the field of neurodegeneration. The conference will host many established speakers in the field and a number of oral presentations will be selected from submitted abstracts.

 Key Sessions

  • Genomic instability and neurodegeneration
  • Genomic instability and ageing
  • Gene therapeutics
 
The conference will bring together scientists and clinicians interested in many aspects of neurodegeneration with the intent of building a comprehensive understanding of this complex process from cause to therapy and will appeal to researchers interested in Neurodegeneration, Ageing, Gene therapy and DNA repair.
 

Related Events

Comments